Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award
Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award Leave a reply Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.” Wiesbaden, November 18, 2025 – At a festive ceremony in the Hessian State Chancellery, Dr. Carl June (University of Pennsylvania) and Dr. Michel Sadelain (Columbia University) were presented with the inaugural Broermann Medical Innovation Award by Minister President Boris Rhein. With a €1 million endowment, the Broermann Award ranks among the world’s most prestigious medical honors. Founded by Dr. Bernard große Broermann, the visionary founder of the Asklepios Group, the award recognizes the pioneering achievements of the two scientists in developing CAR-T cell therapy for the treatment of cancer. In the presence of numerous representatives from science, politics, and society, Minister President Rhein honored the work of the award winners and their contribution to the treatment of cancer patients worldwide: “With their work, Dr. Carl June and Dr. Michel Sadelain demonstrate the immense power that knowledge and passion can unleash. They have the potential to positively impact countless lives.” The head of government presented the Broermann Prize, worth a total of one million euros — one of the world’s most highly endowed awards of its kind praising their “groundbreaking work,” saying: “Dr. Carl June and Dr. Michel Sadelain show that knowledge can change lives and give people new hope for healing.” He further emphasized “The two prizewinners are inspiring role models through their attitude and dedication. With their